TELCON RF PHARMACEUTICAL. Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 3,394.7 million compared to KRW 3,284.98 million a year ago.

Net loss was KRW 42,084.35 million compared to KRW 23,098.05 million a year ago. Basic loss per share from continuing operations was KRW 397 compared to KRW 259 a year ago. Diluted loss per share from continuing operations was KRW 397 compared to KRW 259 a year ago.

Basic loss per share was KRW 397 compared to KRW 263 a year ago.